This is consistent with Misra et al. [22] and TIEN et al. [23] findings, they put forward that Nek2 stimulates the expression of ABC transporters by activation of AKT and its downstream targets PIM1 and NF-kB, resulting in drug resistance of cancer cells. Here, PIM1 is linked to cancer.